Abstract:Background: Total parenteral nutrition (TPN) provides all nutritional needs intravenously. Although lifesaving, enthusiasm is significantly tempered due to side effects of liver and gut injury, as well as lack of mechanistic understanding into drivers of TPN injury. We hypothesized that the state of luminal nutritional deprivation with TPN drives alterations in gut-systemic signaling, contributing to injury, and tested this hypothesis using our ambulatory TPN model. Methods: A total of 16 one-week-old piglets were allocated randomly to TPN (n = 8) or enteral nutrition (EN, n = 8) for 3 weeks. Liver, gut, and serum were analyzed. All tests were two-sided, with a significance level of 0.05. Results: TPN resulted in significant hyperbilirubinemia and cholestatic liver injury, p = 0.034. Hepatic inflammation (cluster of differentiation 3 (CD3) immunohistochemistry) was higher with TPN (p = 0.021). No significant differences in alanine aminotransferase (ALT) or bile ductular proliferation were noted. TPN resulted in reduction of muscularis mucosa thickness and marked gut atrophy. Median and interquartile range for gut mass was 0.46 (0.30-0.58) g/cm in EN, and 0.19 (0.11-0.29) g/cm in TPN (p = 0.024). Key gut-systemic signaling regulators, liver farnesoid X receptor (FXR; p = 0.021), liver constitutive androstane receptor (CAR; p = 0.014), gut FXR (p = 0.028), G-coupled bile acid receptor (TGR5) (p = 0.003), epidermal growth factor (EGF; p = 0.016), organic anion transporter (OAT; p = 0.028), Mitogen-activated protein kinases-1 (MAPK1) (p = 0.037), and sodium uptake transporter sodium glucose-linked transporter (SGLT-1; p = 0.010) were significantly downregulated in TPN animals, whereas liver cholesterol 7 alpha-hydroxylase (CyP7A1) was substantially higher with TPN (p = 0.011). Conclusion: We report significant alterations in key hepatobiliary receptors driving gut-systemic signaling in a TPN piglet model. This presents a major advancement to our understanding of TPN-associated injury and suggests opportunities for strategic targeting of the gut-systemic axis, specifically, FXR, TGR5, and EGF in developing ameliorative strategies.

S1937 Patterns and Predictors of Outcomes in Total Parenteral Nutrition Associated Liver Disease

Endoscopic Nasojejunal Feeding Tube Placement in Patients with Severe Hepatopancreatobiliary Diseases: a Retrospective Study of 184 Patients.

Investigation of parenteral nutrition-induced hepatotoxicity using human liver spheroid co-cultures

Clinical Value of Endoscopic Placement of Nasojejunal Feeding Tube for Nutritional Support in Patients with Severe Acute Pancreatitis

Proteome Characteristics of Liver Tissue from Patients with Parenteral Nutrition-Associated Liver Disease

Refeeding syndrome in adults receiving total parenteral nutrition: An audit of practice at a tertiary UK centre

Impaired Gut-Systemic Signaling Drives Total Parenteral Nutrition-Associated Injury

Long-term assessment of bilirubin and transaminase trends in pediatric intestinal failure patients during the era of hepatoprotective parenteral nutrition

Meta-analysis: Total Parenteral Nutrition Versus Total Enteral Nutrition in Predicted Severe Acute Pancreatitis

The clinical effect of early enteral nutrition in liver-transplanted patients: a systematic review and meta-analysis

Parenteral Nutrition-Associated Liver Disease: The Role of the Gut Microbiota

Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis

Impact of total parenteral nutrition versus exclusive enteral nutrition on postoperative adverse outcomes in patients with penetrating Crohn's disease undergoing surgical resection: A retrospective cohort study

Parenteral nutrition-associated liver injury: clinical relevance and mechanistic insights

A study of pharmacists-joint total parenteral nutrition in haematopoietic cell transplantation in accord with diagnosis related groups: A retrospective clinical research

Treatment-related problems in neonates receiving parenteral nutrition: risk factors and implications for practice

Inflammatory processes involved in the alteration of liver function biomarkers in adult hospitalized patients treated with parenteral nutrition

S1136 Intestinal Transplantation for Inflammatory Bowel Disease: Trends in Cases, Length of Stay, and Survival Odds

Parenteral and enteral nutrition and translational medicine T3: discussion on clinical study design for standardized application and patient benefit

Parenteral Nutrition: Current Use, Complications, and Nutrition Delivery in Critically Ill Patients

Predictors of long-term clinical outcomes after TIPS: An ALTA group study